Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

13.65USD
17 Apr 2014
Price Change (% chg)

$0.15 (+1.11%)
Prev Close
$13.50
Open
$13.48
Day's High
$13.70
Day's Low
$13.43
Volume
2,348,054
Avg. Vol
2,562,558
52-wk High
$14.07
52-wk Low
$7.08

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions,... (more)

Overall

Beta: 1.10
Market Cap (Mil.): $18,065.38
Shares Outstanding (Mil.): 1,323.47
Dividend: --
Yield (%): --

Financials

Search Stocks

FDA OKs new generation Boston Scientific heart pacing devices

- U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.

16 Apr 2014

U.S. FDA OKs new generation Boston Scientific heart pacing devices

April 15 - U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.

16 Apr 2014

Injunction lifted on Boston Scientific catheter product

WASHINGTON - A U.S. appeals court on Tuesday lifted a preliminary injunction on Boston Scientific Corp's catheter product Guidezilla that had been issued by a lower court as part of a patent fight with Vascular Solutions Inc.

15 Apr 2014

UPDATE 1-Injunction lifted on Boston Scientific catheter product

WASHINGTON, April 15 - A U.S. appeals court on Tuesday lifted a preliminary injunction on Boston Scientific Corp's catheter product Guidezilla that had been issued by a lower court as part of a patent fight with Vascular Solutions Inc.

15 Apr 2014

Injunction lifted on Boston Scientific catheter product Guidezilla

WASHINGTON, April 15 - A U.S. appeals court has lifted a preliminary injunction placed on Boston Scientific Corp's catheter product Guidezilla by a lower court, as part of a patent fight with Vascular Solutions Inc.

15 Apr 2014

BRIEF-U.S. appeals court lifts injunction that had favored Vascular Solutions, concerning Boston Scientific catheter

April 15 - * U.S. appeals court rules against Vascular Solutions Inc throws out

15 Apr 2014

Boston Scientific sees opportunity in rival's setback

- Medtronic Inc's stumble in its U.S. medical device study to treat high blood pressure could create an opportunity for other device makers to pick up where their rival has left off, Boston Scientific Corp Chief Executive Mike Mahoney said on Tuesday.

05 Feb 2014

UPDATE 2-Boston Scientific profit up as heart device demand improves

Feb 4 - Boston Scientific Corp on Tuesday reported higher-than-expected quarterly results, citing improving demand for its devices that manage irregular heart rhythms.

04 Feb 2014

Boston Scientific earnings up on heart devices

Feb 4 - Boston Scientific Corp on Tuesday reported higher fourth-quarter earnings on stronger sales of its implantable devices that manage irregular heart rhythms.

04 Feb 2014

U.S. Supreme Court tosses out Medtronic pacemaker patent loss

WASHINGTON - The U.S. Supreme Court on Wednesday ruled in favor of medical devices maker Medtronic Inc in its dispute with privately owned Mirowski Family Ventures LLC over whether the larger company infringed on Mirowski's patents in making certain pacemakers.

23 Jan 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $98.96 +0.21
Medtronic, Inc. (MDT.N) $58.55 +0.06
Abbott Laboratories (ABT.N) $38.93 +0.55
St. Jude Medical, Inc. (STJ.N) $62.49 +0.45

Earnings vs. Estimates

Search Stocks